Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease (Q34537639)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease |
scientific article |
Statements
1 reference
Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease (English)
1 reference
Kirsten Bibbins-Domingo
1 reference
Dhruv S Kazi
1 reference
Andrew E Moran
1 reference
Pamela G Coxson
1 reference
Joanne Penko
1 reference
Daniel A Ollendorf
1 reference
Steven D Pearson
1 reference
Jeffrey A Tice
1 reference
David Guzman
1 reference
1 August 2016
1 reference
1 reference
Identifiers
1 reference